4
Changes in Ownership
Caribou Biosciences, Inc. Filed Acc 0001209191-21-060424
Chief Scientific Officer bought 114,860 shares at an average $1.92 ($220,757)
From the SEC's structured data for this filing
Trades in this filing
Kanner Steven · Chief Scientific Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-10-12 | Purchase : show line 1 in the form | +99,548 | $1.81 | $180,182 | 199,719 | D |
| 2021-10-12 | Purchase : show line 2 in the form | +698 | $1.81 | $1,263 | 200,417 | D |
| 2021-10-12 | Purchase : show line 3 in the form | +14,614 | $2.69 | $39,312 | 215,031 | D |
| Open-market purchases · 114,860 sh · avg $1.92 · $220,757 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-10-12 | Option exercise : show line 4 in the form Option to purchase Common Stock | −99,548 | 71,840 | D |
| 2021-10-12 | Option exercise : show line 5 in the form Option to purchase Common Stock | −698 | 4,879 | D |
| 2021-10-12 | Option exercise : show line 6 in the form Option to purchase Common Stock | −14,614 | 132,134 | D |
Loading xslF345X03/doc4.xml…